Semaglutide Wegovy / Ozempic Mechanism: GLP-1 receptor agonist (single target) Weight loss: ~15-17% body weight (STEP trials, 68 weeks) Dosing: Weekly injection, titrated from 0.25mg to 2.4mg Common side effects: Nausea, vomiting, diarrhea, constipation (typically transient) Availability: Longer track record, more widely available Cardiovascular data: SELECT trial demonstrated 20% reduction in major cardiovascular events Tirzepatide Zepbound / Mounjaro Mechanism: Dual GLP-1 + GIP receptor agonist (two targets) Weight loss: ~20-22% body weight (SURMOUNT trials, 72 weeks) Dosing: Weekly injection, titrated from 2.5mg to 15mg Common side effects: Similar GI profile to semaglutide

Visual Format: Approved vs investigational status map Key Labels: Cosmetic product, compounded peptide, non-injectable route, injectable route, FDA safety concern, approved drug label, regulatory standards, product category Suggested Layout: Use a horizontal status map with four blocks: Cosmetic context, Non-injectable compounding review, Injectable safety concern, and Approved drug labeling. Add a note that product category changes evidence and safety interpretation
compounding pharmacies and has not been reviewed by the FDA for safety, effectiveness, or quality
A site tracker tells you where you injected
10.1016/j.lfs.2023.121915 36 PickartL
contains Acetyl-L-carnitine 250 capsules made from plant cellulose (HPMC) free from colourings and preservatives without anti-caking agents such as magnesium stearate non-GMO lactose-free, gluten-free and vegan 47.70 Available immediately, ready for shipment within 1-2 working days Produktinformationen L-carnitine supplies the cellular powerhouses with fuel L-carnitine plays a fundamental role in fat metabolism